93 Results (Page 1 of 8)
Saudi Arabia Markets Research Reports
Saudi Arabia Diabetes Devices Market Analysis
The Saudi Arabia Diabetes Devices Market is expected to witness growth from $386 Mn in 2022 to $753 Mn in 2030 with a CAGR of 8.70% for the forecasted year 2022-2030. One of the greatest rates of diabetes is found in Saudi Arabia. As more individuals need access to blood glucose monitors, insulin pumps, and other diabetes management tools, this expands the market for diabetes devices. The market is segmented by type and by the end user. Some key players in this market include Aljeel Medical, Alhammad Medical, Medyssey, Johnson & Johnson, Philipps Healthcare, Medtronic, Roche and Dexcom.
Saudi Arabia Cardiac Surgery Instruments Market Analysis
The Saudi Arabia Cardiac Surgery Instruments Market is expected to witness growth from $35 Mn in 2022 to $66 Mn in 2030 with a CAGR of 8.10% for the forecasted year 2022-2030. In Saudi Arabia, the incidence of cardiovascular diseases such as coronary heart disease, stroke, and hypertension is rising. In order to diagnose, treat, and control these conditions, cardiac surgery equipment is in high demand. The market is segmented by type, application and by end user. Some key players in this market include Al Madar Medical, Aljeel Medical, Alhammad medical, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Saudi Arabia Artificial Intelligence (AI) in Healthcare Market Analysis
Saudi Arabia's Artificial Intelligence (AI) In Healthcare Market is projected to grow from $0.12 Bn in 2022 to $2.52 Bn by 2030, registering a CAGR of 46.72% during the forecast period of 2022 - 2030. The market will be driven by the growing demand for more cost-effective healthcare solutions and the government's support for the use of artificial intelligence in healthcare. The market is segmented by healthcare components & by healthcare applications. Some of the major players include IBM Watson Health, Google DeepMind Health & Cura.
Saudi Arabia Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the Saudi Arabia Liver Disease Therapeutics market will reach a value of $685 Mn from $393 Mn in 2022, growing at a CAGR of 7.2% during 2022-2030. Liver Disease Therapeutics in Saudi Arabia is dominated by a few domestic pharmaceutical companies such as Tabuk Pharmaceuticals, Jamjoom Pharma, and SPIMACO. The Liver Disease Therapeutics market in Saudi Arabia is segmented into different types of disease and different therapy types. Some of the major factors affecting the Saudi Arabia Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
Saudi Arabia Healthcare Insurance Market Analysis
The Saudi Arabia healthcare insurance market is projected to grow from $34.45 Bn in 2022 to $69.14 Bn by 2030, registering a CAGR of 9.1% during the forecast period of 2022 - 2030. The main factors driving the growth would be mandatory health insurance schemes, growing healthcare infrastructure, increasing prevalence of non-communicable diseases, and government support. The market is segmented by component, provider, coverage, by health insurance plans and end-user. Some of the major players include Tawuniya, MedGulf, Saudi Arabian Cooperative Insurance Company (SAICO), Al Rajhi Takaful and Bupa Arabia.
Saudi Arabia Anti Aging Therapeutics Market Analysis
Saudi Arabia anti-aging therapeutics market is projected to grow from $10 Mn in 2022 to $39 Mn in 2030 with a CAGR of 18.03% for the year 2022-2030. The rising awareness in the Saudi Arabian population about anti-aging treatments and therapies is the major growth driver in the market. The Saudi Arabia anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Voirx, Wayakit, and IRIDEX Corporation are some of the key companies in the market.
Saudi Arabia Biomaterials in Healthcare Market Analysis
The Saudi Arabia Biomaterials Healthcare Market is expected to witness growth from $2.65 Bn in 2022 to $7.95 Bn in 2030 with a CAGR of 14.70% for the forecasted year 2022-2030. Saudi Arabia's longevity and rise in persistent illnesses are driving up demand for medical implants, including spinal implants, dental implants, and joint replacements. The demand for biomaterials used in medical implants is anticipated to increase as a result of this demand. The market is segmented by type and by application. Some key players in this market include: Alhammad medical, Almarfa Medical, BASF SE, Johnson and Johnson, Medtronic and Evonik Industries.
Saudi Arabia ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
Saudi Arabia's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is expected to witness growth from $503 Mn in 2022 to $1,001 Mn in 2030 with a CAGR of 9% for the year 2022-2030. New product launches, approval of new medicines, and increased research and development activities in ADHD therapeutics in Saudi Arabia will drive the growth of the market during the forecast period. The Saudi Arabia ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Some of the key competitors in the market are Softec Pharma, Al-Dawa, and Eli Lily.
Saudi Arabia 3D Printing Medical Devices Market Analysis
Saudi Arabia 3D Printing Medical Device Market is expected to witness growth from $50 Mn in 2022 to $187 Mn in 2030 with a CAGR of 17.80% for the forecasted year 2022-2030. In Saudi Arabia, the prevalence of chronic diseases like diabetes, cancer, and cardiovascular disease is rising. As a result, there is an expanding need for 3D-printed medical devices that can be used for the diagnosis and treatment of these diseases. The market is segmented by application, by technology and by end user. Some key players in this market include: Saudi Print 3D, Al Amin Medical Instruments, GE Healthcare, Stryker and Siemens Healthineers
Saudi Arabia Oncology Clinical Trials Market Analysis
Saudi Arabia's Oncology Clinical Trials Market is projected to grow from $215.1 Mn in 2022 to $369.5 Mn by 2030, registering a CAGR of 7% during the forecast period of 2022-30. The market will be driven by the need for improved cancer treatment alternatives and the rise in collaborations between Saudi Arabian research institutes and foreign organizations. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Roche Holding AG & Tabuk Pharmaceuticals.
Saudi Arabia Healthcare Claims Management Market Analysis
The Saudi Arabia healthcare claims management market is projected to grow from $453.9 Mn in 2022 to $2688.19 Mn by 2030, registering a CAGR of 24.9% during the forecast period of 2022 - 2030. The main factors driving the growth would be the increasing prevalence of chronic disease, government initiatives, adoption of digital solutions and growth in healthcare spending. The market is segmented by component, type, by delivery mode and end-user. Some of the major players include Tawuniya, Total Care Saudi, MedNet and Cognizant.
Saudi Arabia Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Saudi Arabia Liver Cancer Therapeutics market will reach a value of $201.7 Mn from $49.8 Mn in 2022, growing at a CAGR of 19.1 % during 2022-2030. Liver Cancer Therapeutics in Saudi Arabia is dominated by a few domestic pharmaceutical companies such as Jamjoom Pharma, Tabuk Pharmaceuticals and SPIMACO. The Liver Cancer Therapeutics market in Saudi Arabia is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Saudi Arabia Liver Cancer Therapeutics market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
Saudi Arabia Connected Healthcare Market Analysis
The Saudi Arabia-connected healthcare market is projected to grow from $1.13 Bn in 2022 to $9.15 Bn by 2030, registering a CAGR of 29.9% during the forecast period of 2022 - 2030. The main factors driving the growth would be government support, technological advancements, increasing investment in the sector, increasing prevalence of chronic diseases. The market is segmented by type, function and application. Some of the major players include Cura, Seha Virtual Hospital, Saudi Telecom Company, GE Healthcare, Honeywell and Apple.
Saudi Arabia Neurology Clinical Trials Market Analysis
The Saudi Arabia Neurology Clinical Trials market is projected to grow from $88.9 Mn in 2022 to $152.8 Mn by 2030, registering a CAGR of 7% during the forecast period of 2022 - 2030. The market will be driven by the high prevalence of neurological disorders, and increasing investment in healthcare infrastructure. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Novartis AG & Tabuk Pharmaceuticals.
Saudi Arabia Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the Saudi Arabia infectious disease therapeutics market will reach a value of $3.21 Bn from $2.04 Bn in 2022, growing at a CAGR of 5.9% during 2022-2030. The Infectious Disease Therapeutics in Saudi Arabia is dominated by a few domestic pharmaceutical companies such as SPIMACO, Tabuk Pharmaceuticals and Taibah Valley. The Infectious Disease Therapeutics market in Saudi Arabia is segmented into different therapeutic areas and different diseases type. The major factors affecting the Saudi Arabia infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the amount of healthcare funding for infectious diseases treatment in various areas of Saudi Arabia.
Saudi Arabia Patient Engagement Solutions Market Analysis
The Saudi Arabia patient engagement solutions market is projected to grow from $289.17 Mn in 2022 to $807.68 Mn by 2030, registering a CAGR of 13.7% during the forecast period of 2022 - 2030. The main factors driving the growth would be advancements in technology, a focus on patient-centred care and government support. The market is segmented by component, delivery mode, application, therapeutic area, functionality and by end-user. Some of the major players include ArabiaTek, CloudPital, GE Healthcare, Siemens Healthineers and Wolters Kluwer.
Saudi Arabia Artificial Intelligence (AI) in Diagnostics Market Analysis
Saudi Arabia's Artificial Intelligence (AI) in the diagnostics market is projected to grow from $17 Mn in 2022 to $204.9 Mn by 2030, registering a CAGR of 36.5% during the forecast period of 2022-2030. The market will be driven by the increased need for efficient and accurate diagnostic tools and investments in healthcare infrastructure by the government. The market is segmented by component & by diagnosis. Some significant players include IBM Watson Health, Siemens Healthineers & Philips Healthcare.
Saudi Arabia Nutritional Supplements Market Analysis
By 2030, it is anticipated that the Saudi Arabia Nutrition and Supplements market will reach a value of $13.9 Bn from $6.49 Bn in 2022, growing at a CAGR of 10% during 2022-2030. The nutrition and supplements market in Saudi Arabia is primarily dominated by local players such as Vitabiotics Ltd, SEWAR, and BIOVEA. The market for nutrition and supplements in Saudi Arabia is primarily driven by an inclination towards better health infrastructure, government regulations and increasing consumer awareness of health and lifestyle. The Saudi Arabia nutrition and supplements market is segmented by Type, Product, and application, and Distribution Channel.
Saudi Arabia 3D Imaging Market Analysis
The Saudi Arabia 3D Imaging market is projected to grow from $0.52 Bn in 2022 to $1.94 Bn by 2030, registering a CAGR of 18% during the forecast period of 2022 - 2030. The market will be driven by increasing awareness of the advantages of 3D Imaging and government initiatives such as collaborations and privatization. The market is segmented by product, application, by end-user & by portability. Some of the major players include GE Healthcare, Siemens Healthineers & Philips Healthcare.
Saudi Arabia HIV Therapeutics Market Analysis
The Saudi Arabia HIV therapeutics market is expected to reach $325.09 Mn by 2030, up from $233.92 Mn in 2022, with a CAGR of 4.2% from 2022 to 2030. Local players such as SPIMACO, Tabuk Pharmaceuticals, and Jamjoom Pharma dominate the HIV therapeutics market in Saudi Arabia. Government policies, funding, and initiatives to manage HIV infections in the country propel market growth. The HIV therapeutics market in Saudi Arabia is divided into four segments: type, product, geography, end user, and distribution channel.
Saudi Arabia Palliative Care Market Analysis
The Saudi Arabia Palliative care market is projected to grow from $222.36 Mn in 2022 to $459.59 Mn by 2030, registering a CAGR of 9.5% during the forecast period of 2022 - 2030. The main factors driving the growth would be an increasing aging population, a rise in the prevalence of chronic diseases, and government support. The market is segmented by service type and by the end user. Some of the major players include King Fahad Medical City, King Faisal Specialist Hospital, and Research Center, Salam Medical, and others.
Saudi Arabia Cancer Pain Management Market Analysis
The Saudi Arabia Cancer Pain Management market is projected to grow from $110.84 Mn in 2022 to $187.61 Mn by 2030, registering a CAGR of 6.8% during the forecast period of 2022-30. The main factors driving the growth would be increasing awareness about cancer pain management solutions and the rising prevalence of cancer cases. The market is segmented by drug type and by disease. Some of the major players include Tabuk Pharmaceuticals (SAU), Mundipharma, Abbott, Sanofi, and Medtronic.
Saudi Arabia Home Healthcare Market Analysis
The Saudi Arabia home healthcare market was valued at $6.16 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 9.43% from 2022 to 2030 and will reach $12.67 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and the aging population. The market is segmented by indication and product. Some key players in this market are Saudi Home Healthcare Society, Fresenius Medical Care AG & Co KGaA, General Electric, LINDE, F. HOFFMANN-LA ROCHE, SALAM Al-Motamayeza Medical Services Co.
Saudi Arabia Electronic Health Records Market Analysis
The Saudi Arabia Electronic Health Record (EHR) market size was valued at $448 Mn in 2022 and is estimated to expand at a CAGR of 5.5% from 2022 to 2030 and will reach $738 Mn in 2030. Saudi Arabia EHR market growth can be attributed to the surging need for remote monitoring and chronic disease management. The market is segmented by product type, application type, and end user. The key market players are Al Muhaidib Group (SAU), Sada Systems (SAU), Allscripts, Cerner, and others.
Saudi Arabia Bioinformatics Market Analysis
The Saudi Arabia Bioinformatics market is projected to grow from $260.95 Mn in 2022 to $967.65 Mn by 2030, registering a CAGR of 17.8% during the forecast period of 2022 - 2030. The main factors driving the growth would be government initiatives, increasing adoption of precision medicine, strong economic growth, and the growing healthcare industry. The market is segmented by technology and by application. Some of the major players include Faizgen (SAU), Noor Diagnostics and Discovery (SAU), IBM Life Sciences, Graphstats Technologies, and 3rd Millennium.